Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 873

1.

Levothyroxine tablet (Thyradin-S)-induced autoimmune-like hepatitis following post-transplant Hashimoto's thyroiditis in a patient after allogenic bone marrow transplantation.

Okamura-Shiki I, Moriguchi M, Uehara T, Fukaya M, Kakuda Y, Nakanuma Y, Ikeda T.

Leuk Lymphoma. 2019 Aug;60(8):2082-2084. doi: 10.1080/10428194.2018.1563695. Epub 2019 Jun 17. No abstract available.

PMID:
31204871
2.

The Pathologic and Genetic Characteristics of the Intestinal Subtype of Intraductal Papillary Neoplasms of the Bile Duct.

Nakanuma Y, Kakuda Y, Fukumura Y, Sugino T, Uesaka K, Serizawa M, Terada T, Ohnishi Y.

Am J Surg Pathol. 2019 Jun 3. doi: 10.1097/PAS.0000000000001295. [Epub ahead of print]

PMID:
31166202
3.

The Evaluation of the Eighth Edition of the AJCC/UICC Staging System for Intrahepatic Cholangiocarcinoma: a Proposal of a Modified New Staging System.

Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Ohgi K, Nakanuma Y, Uesaka K.

J Gastrointest Surg. 2019 Apr 22. doi: 10.1007/s11605-019-04185-1. [Epub ahead of print]

PMID:
31012045
4.
5.

Comparison of the Clinicopathological Features in Small Bile Duct and Bile Ductular Type Intrahepatic Cholangiocarcinoma.

Yamada M, Yamamoto Y, Sugiura T, Kakuda Y, Ashida R, Tamura S, Okamura Y, Ito T, Ohgi K, Nakanuma Y, Uesaka K.

Anticancer Res. 2019 Apr;39(4):2121-2127. doi: 10.21873/anticanres.13325.

PMID:
30952758
6.

Cholangiolocellular Carcinoma With "Ductal Plate Malformation" Pattern May Be Characterized by ARID1A Genetic Alterations.

Sasaki M, Sato Y, Nakanuma Y.

Am J Surg Pathol. 2019 Mar;43(3):352-360. doi: 10.1097/PAS.0000000000001201.

PMID:
30520820
7.

The Radiological Differentiation of Hypervascular Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma with a Focus on the CT Value on Multi-phase Enhanced CT.

Sano S, Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Ohgi K, Aramaki T, Nakanuma Y, Uesaka K.

Anticancer Res. 2018 Sep;38(9):5505-5512. doi: 10.21873/anticanres.12884.

PMID:
30194209
8.

Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension: nomenclature and definition.

Guido M, Alves VAF, Balabaud C, Bathal PS, Bioulac-Sage P, Colombari R, Crawford JM, Dhillon AP, Ferrell LD, Gill RM, Hytiroglou P, Nakanuma Y, Paradis V, Quaglia A, Rautou PE, Theise ND, Thung S, Tsui WMS, Sempoux C, Snover D, van Leeuwen DJ; International Liver Pathology Study Group.

Histopathology. 2019 Jan;74(2):219-226. doi: 10.1111/his.13738. Epub 2018 Oct 17. Review.

PMID:
30129657
9.

The Clinical Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Occupational Cholangiocarcinoma

Kinoshita M, Takemura S, Tanaka S, Shinkawa H, Hamano G, Ito T, Koda M, Aota T, Nakanuma Y, Sato Y, Nakamori S, Arimoto A, Yamamoto T, Toyokawa H, Kubo S.

Asian Pac J Cancer Prev. 2018 Jul 27;19(7):1753-1759.

10.

Acute-on-chronic liver failure 2018: a need for (urgent) liver biopsy?

van Leeuwen DJ, Alves V, Balabaud C, Bhathal PS, Bioulac-Sage P, Colombari R, Crawford JM, Dhillon AP, Ferrell L, Gill RM, Guido M, Hytiroglou P, Nakanuma Y, Paradis V, Rautou PE, Sempoux C, Snover DC, Theise ND, Thung SN, Tsui WMS, Quaglia A, Liver Pathology Study Group TI.

Expert Rev Gastroenterol Hepatol. 2018 Jun;12(6):565-573. doi: 10.1080/17474124.2018.1481388. Epub 2018 Jun 14. Review.

PMID:
29806950
11.

Surgical Indication for Advanced Intrahepatic Cholangiocarcinoma According to the Optimal Preoperative Carbohydrate Antigen 19-9 Cutoff Value.

Yamamoto Y, Sugiura T, Todaka A, Okamura Y, Ito T, Ashida R, Kakuda Y, Nakanuma Y, Uesaka K.

World J Surg. 2018 Oct;42(10):3331-3340. doi: 10.1007/s00268-018-4605-y.

PMID:
29619514
12.

An impaired biliary bicarbonate umbrella may be involved in dysregulated autophagy in primary biliary cholangitis.

Sasaki M, Sato Y, Nakanuma Y.

Lab Invest. 2018 Jun;98(6):745-754. doi: 10.1038/s41374-018-0045-4. Epub 2018 Mar 14.

13.

Effect of deferred or no treatment with ursodeoxycholic acid in patients with early primary biliary cholangitis.

Tanaka A, Hirohara J, Nakano T, Yagi M, Namisaki T, Yoshiji H, Nakanuma Y, Takikawa H; Japan PBC Study Group (JPBCSG).

Hepatol Res. 2018 Aug;48(9):727-734. doi: 10.1111/hepr.13068. Epub 2018 Mar 7.

PMID:
29405510
14.

cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation.

Brunt E, Aishima S, Clavien PA, Fowler K, Goodman Z, Gores G, Gouw A, Kagen A, Klimstra D, Komuta M, Kondo F, Miksad R, Nakano M, Nakanuma Y, Ng I, Paradis V, Nyun Park Y, Quaglia A, Roncalli M, Roskams T, Sakamoto M, Saxena R, Sempoux C, Sirlin C, Stueck A, Thung S, Tsui WMS, Wang XW, Wee A, Yano H, Yeh M, Zen Y, Zucman-Rossi J, Theise N.

Hepatology. 2018 Jul;68(1):113-126. doi: 10.1002/hep.29789. Epub 2018 May 9.

15.

A statement by the Japan-Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage.

Nakanuma Y, Jang KT, Fukushima N, Furukawa T, Hong SM, Kim H, Lee KB, Zen Y, Jang JY, Kubota K.

J Hepatobiliary Pancreat Sci. 2018 Mar;25(3):181-187. doi: 10.1002/jhbp.532. Epub 2018 Feb 12. Review.

PMID:
29272078
16.

NEDD4-family E3 ligase dysfunction due to PKHD1/Pkhd1 defects suggests a mechanistic model for ARPKD pathobiology.

Kaimori JY, Lin CC, Outeda P, Garcia-Gonzalez MA, Menezes LF, Hartung EA, Li A, Wu G, Fujita H, Sato Y, Nakanuma Y, Yamamoto S, Ichimaru N, Takahara S, Isaka Y, Watnick T, Onuchic LF, Guay-Woodford LM, Germino GG.

Sci Rep. 2017 Aug 10;7(1):7733. doi: 10.1038/s41598-017-08284-4.

17.

Clinicopathological features of intraductal papillary neoplasms of the bile duct: a comparison with intraductal papillary mucinous neoplasm of the pancreas with reference to subtypes.

Fukumura Y, Nakanuma Y, Kakuda Y, Takase M, Yao T.

Virchows Arch. 2017 Jul;471(1):65-76. doi: 10.1007/s00428-017-2144-9. Epub 2017 May 26.

PMID:
28550497
18.

Gadoxetic acid-enhanced magnetic resonance imaging reflects co-activation of β-catenin and hepatocyte nuclear factor 4α in hepatocellular carcinoma.

Kitao A, Matsui O, Yoneda N, Kozaka K, Kobayashi S, Koda W, Minami T, Inoue D, Yoshida K, Yamashita T, Yamashita T, Kaneko S, Takamura H, Ohta T, Ikeda H, Sato Y, Nakanuma Y, Harada K, Kita R, Gabata T.

Hepatol Res. 2018 Feb;48(2):205-216. doi: 10.1111/hepr.12911. Epub 2017 Jun 13.

PMID:
28488786
19.

Expression and localization of sterile alpha motif domain containing 5 is associated with cell type and malignancy of biliary tree.

Yagai T, Matsui S, Harada K, Inagaki FF, Saijou E, Miura Y, Nakanuma Y, Miyajima A, Tanaka M.

PLoS One. 2017 Apr 7;12(4):e0175355. doi: 10.1371/journal.pone.0175355. eCollection 2017.

20.

Intraductal neoplasms of the bile duct. A new challenge to biliary tract tumor pathology.

Nakanuma Y, Uesaka K, Miyayama S, Yamaguchi H, Ohtsuka M.

Histol Histopathol. 2017 Oct;32(10):1001-1015. doi: 10.14670/HH-11-892. Epub 2017 Mar 24. Review.

PMID:
28337739
21.

Bile Acids and Deregulated Cholangiocyte Autophagy in Primary Biliary Cholangitis.

Sasaki M, Nakanuma Y.

Dig Dis. 2017;35(3):210-216. doi: 10.1159/000450913. Epub 2017 Mar 1. Review.

PMID:
28249264
22.

The PD-1/PD-L1 axis may be aberrantly activated in occupational cholangiocarcinoma.

Sato Y, Kinoshita M, Takemura S, Tanaka S, Hamano G, Nakamori S, Fujikawa M, Sugawara Y, Yamamoto T, Arimoto A, Yamamura M, Sasaki M, Harada K, Nakanuma Y, Kubo S.

Pathol Int. 2017 Mar;67(3):163-170. doi: 10.1111/pin.12511. Epub 2017 Jan 31.

PMID:
28139862
23.

Biliary tumors with pancreatic counterparts.

Nakanuma Y, Sudo Y.

Semin Diagn Pathol. 2017 Mar;34(2):167-175. doi: 10.1053/j.semdp.2016.12.013. Epub 2016 Dec 20.

PMID:
28109714
24.

An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma.

Nakanuma Y, Uchida T, Sato Y, Uesaka K.

Hum Pathol. 2017 Feb;60:46-57. doi: 10.1016/j.humpath.2016.10.003. Epub 2016 Oct 28.

PMID:
27984121
25.

Dynamic CT findings of cholangiolocellular carcinoma: correlation with angiography-assisted CT and histopathology.

Kozaka K, Matsui O, Kobayashi S, Koda W, Minami T, Kitao A, Inoue D, Yoneda N, Yoshida K, Toshima F, Nakanuma Y, Gabata T.

Abdom Radiol (NY). 2017 Mar;42(3):861-869. doi: 10.1007/s00261-016-0944-z.

PMID:
27747442
26.

Cystic and Papillary Neoplasm at the Hepatic Hilum Possibly Originating in the Peribiliary Glands.

Miyata T, Uesaka K, Nakanuma Y.

Case Rep Pathol. 2016;2016:9130754. doi: 10.1155/2016/9130754. Epub 2016 Aug 31.

27.

Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance.

Sasaki M, Sato Y, Nakanuma Y.

Histopathology. 2017 Feb;70(3):423-434. doi: 10.1111/his.13084. Epub 2016 Nov 15.

PMID:
27634656
28.

Stress-induced cellular responses and cell death mechanisms during inflammatory cholangiopathies.

Sasaki M, Nakanuma Y.

Clin Res Hepatol Gastroenterol. 2017 Mar;41(2):129-138. doi: 10.1016/j.clinre.2016.08.002. Epub 2016 Sep 9. Review.

PMID:
27618480
29.

Histopathology of IgG4-Related Autoimmune Hepatitis and IgG4-Related Hepatopathy in IgG4-Related Disease.

Nakanuma Y, Ishizu Y, Zen Y, Harada K, Umemura T.

Semin Liver Dis. 2016 Aug;36(3):229-41. doi: 10.1055/s-0036-1584320. Epub 2016 Jul 28.

PMID:
27466793
30.

Vascularity of Intrahepatic Cholangiocarcinoma on Computed Tomography is Predictive of Lymph Node Metastasis.

Yamamoto Y, Türkoğlu MA, Aramaki T, Sugiura T, Okamura Y, Ito T, Ashida R, Uemura S, Miyata T, Kato Y, Kakuta Y, Nakanuma Y, Uesaka K.

Ann Surg Oncol. 2016 Aug;23(Suppl 4):485-493. Epub 2016 Jul 8.

PMID:
27393571
31.

Outcomes after resection of occupational cholangiocarcinoma.

Kubo S, Takemura S, Tanaka S, Shinkawa H, Kinoshita M, Hamano G, Ito T, Koda M, Aota T, Yamamoto T, Terajima H, Tachiyama G, Yamada T, Nakamori S, Arimoto A, Fujikawa M, Tomimaru Y, Sugawara Y, Nakagawa K, Unno M, Mizuguchi T, Takenaka K, Kimura K, Shirabe K, Saiura A, Uesaka K, Taniguchi H, Fukuda A, Chong JM, Kuwae Y, Ohsawa M, Sato Y, Nakanuma Y.

J Hepatobiliary Pancreat Sci. 2016 Sep;23(9):556-64. doi: 10.1002/jhbp.373. Epub 2016 Aug 1.

PMID:
27363864
32.

Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.

Shoda J, Matsuda A, Shida T, Yamamoto M, Nagino M, Tsuyuguchi T, Yasaka T, Tazuma S, Uchiyama K, Unno M, Ohkohchi N, Nakanuma Y, Kuno A, Narimatsu H.

J Gastroenterol. 2017 Feb;52(2):218-228. doi: 10.1007/s00535-016-1230-0. Epub 2016 Jun 29.

33.

Loss of ARID1A Expression Presents a Novel Pathway of Carcinogenesis in Biliary Carcinomas.

Sasaki M, Nitta T, Sato Y, Nakanuma Y.

Am J Clin Pathol. 2016 Jun;145(6):815-25. doi: 10.1093/ajcp/aqw071.

PMID:
27334809
34.

The favorable prognosis after operative resection of hypervascular intrahepatic cholangiocarcinoma: A clinicopathologic and immunohistochemical study.

Türkoğlu MA, Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Uemura S, Miyata T, Kakuda Y, Nakanuma Y, Uesaka K.

Surgery. 2016 Sep;160(3):683-90. doi: 10.1016/j.surg.2016.03.020. Epub 2016 May 4.

PMID:
27155908
35.

Characterization of intraductal papillary neoplasm of bile duct with respect to histopathologic similarities to pancreatic intraductal papillary mucinous neoplasm.

Nakanuma Y, Kakuda Y, Uesaka K, Miyata T, Yamamoto Y, Fukumura Y, Sato Y, Sasaki M, Harada K, Takase M.

Hum Pathol. 2016 May;51:103-13. doi: 10.1016/j.humpath.2015.12.022. Epub 2016 Jan 19.

PMID:
27067788
36.

Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: implications for liver biopsy interpretation.

Quaglia A, Alves VA, Balabaud C, Bhathal PS, Bioulac-Sage P, Crawford JM, Dhillon AP, Ferrell L, Guido M, Hytiroglou P, Nakanuma Y, Paradis V, Snover DC, Theise ND, Thung SN, Tsui WM, van Leeuwen DJ; International Liver Pathology Study Group.

Histopathology. 2016 Jun;68(7):953-67. doi: 10.1111/his.12957. Epub 2016 Apr 28. Review.

PMID:
26918878
37.

Cystic micropapillary neoplasm of peribiliary glands with concomitant perihilar cholangiocarcinoma.

Uchida T, Yamamoto Y, Ito T, Okamura Y, Sugiura T, Uesaka K, Nakanuma Y.

World J Gastroenterol. 2016 Feb 21;22(7):2391-7. doi: 10.3748/wjg.v22.i7.2391.

38.

Functional Immune Anatomy of the Liver-As an Allograft.

Demetris AJ, Bellamy CO, Gandhi CR, Prost S, Nakanuma Y, Stolz DB.

Am J Transplant. 2016 Jun;16(6):1653-80. doi: 10.1111/ajt.13749. Epub 2016 Mar 21. Review.

39.

"Biliary Diseases with Pancreatic Counterparts": Cross-sectional Imaging Findings.

Katabathina VS, Flaherty EM, Dasyam AK, Menias CO, Riddle ND, Lath N, Kozaka K, Matsui O, Nakanuma Y, Prasad SR.

Radiographics. 2016 Mar-Apr;36(2):374-92. doi: 10.1148/rg.2016150071. Epub 2016 Feb 1. Review.

PMID:
26824512
40.

Comparison of Liver Biopsy Findings with the Digestive Disease Week Japan 2004 Scale for Diagnosis of Drug-Induced Liver Injury.

Tsutsui A, Nakanuma Y, Takaguchi K, Nakamura S, Shibata H, Baba N, Senoh T, Nagano T, Ikeda H.

Mediators Inflamm. 2015;2015:913793. doi: 10.1155/2015/913793. Epub 2015 Nov 1.

41.

Pre-invasive intraductal papillary neoplasm of the pancreatobiliary system.

Nakanuma Y.

Clin Res Hepatol Gastroenterol. 2016 Apr;40(2):133-5. doi: 10.1016/j.clinre.2015.12.005. Epub 2016 Jan 13. No abstract available.

PMID:
26774364
42.

New concept: cellular senescence in pathophysiology of cholangiocarcinoma.

Sasaki M, Nakanuma Y.

Expert Rev Gastroenterol Hepatol. 2016;10(5):625-38. doi: 10.1586/17474124.2016.1133291. Epub 2016 Jan 8. Review.

PMID:
26680649
43.

Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E.

Ni Y, Nagashimada M, Zhuge F, Zhan L, Nagata N, Tsutsui A, Nakanuma Y, Kaneko S, Ota T.

Sci Rep. 2015 Nov 25;5:17192. doi: 10.1038/srep17192.

44.

Pathological spectrum of bile duct lesions from chronic bile duct injury to invasive cholangiocarcinoma corresponding to bile duct imaging findings of occupational cholangiocarcinoma.

Kinoshita M, Kubo S, Nakanuma Y, Sato Y, Takemura S, Tanaka S, Hamano G, Ito T, Terajima H, Yamada T, Nakamori S, Arimoto A, Fujikawa M, Sugawara Y, Yamamoto T, Abue M, Nakagawa K, Unno M, Mizuguchi T, Takenaka K, Shirabe K, Shibata T.

J Hepatobiliary Pancreat Sci. 2016 Feb;23(2):92-101. doi: 10.1002/jhbp.305. Epub 2015 Dec 30.

PMID:
26580863
45.

Latest advances in the pathological understanding of cholangiocarcinomas.

Nakanuma Y, Miyata T, Uchida T.

Expert Rev Gastroenterol Hepatol. 2016;10(1):113-27. doi: 10.1586/17474124.2016.1104246. Epub 2015 Oct 22. Review.

PMID:
26492529
46.

Clinical features of hepatolithiasis: analyses of multicenter-based surveys in Japan.

Tazuma S, Nakanuma Y.

Lipids Health Dis. 2015 Oct 17;14:129. doi: 10.1186/s12944-015-0130-2.

47.

Serum Amyloid A-Positive Hepatocellular Neoplasm: A New Type of Tumor Arising in Patients with Advanced Alcoholic Disease.

Sasaki M, Nakanuma Y.

Dig Dis. 2015 Sep;33(5):648-54. doi: 10.1159/000438474. Epub 2015 Sep 23. Review.

PMID:
26398230
48.

Pathological characteristics of intraductal polypoid neoplasms of bile ducts in Thailand.

Nitta T, Nakanuma Y, Sato Y, Hirano S, Pairojkul C.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8284-90. eCollection 2015.

49.

In recurrent primary biliary cirrhosis after liver transplantation, biliary epithelial cells show increased expression of mitochondrial proteins.

Sasaki M, Hsu M, Yeh MM, Nakanuma Y.

Virchows Arch. 2015 Oct;467(4):417-25. doi: 10.1007/s00428-015-1819-3. Epub 2015 Aug 11.

PMID:
26259963
50.

Biliary adenofibroma with ominous features of imminent malignant changes.

Tsutsui A, Bando Y, Sato Y, Miyake H, Sawada-Kitamura S, Shibata H, Kakuda Y, Harada K, Sasaki M, Nakanuma Y.

Clin J Gastroenterol. 2014 Oct;7(5):441-8. doi: 10.1007/s12328-014-0523-1. Epub 2014 Aug 20.

PMID:
26184026

Supplemental Content

Loading ...
Support Center